Abraham founded AG Mednet in 2005 after selling his previous company to AT&T. He is a technologist with 35 years of experience in the conception, implementation and sales of advanced software systems and platforms in fields including Telecommunications and Life Sciences. He holds a B.A. in Computer Science from Cornell, and an M.S. in Computer Science (AI) from Yale.

JP brings with him over 15 years of experience in the technology space, where he has developed a reputation for driving transformation, efficiency, and scalability in high-growth organizations. JP joins AG Mednet from Common Energy in New York, where he served as COO of the community solar startup that manages solar farms on behalf of solar developers. Prior to that, he worked with world-renowned consulting firms McKinsey & Company and Gerson Lehrman Group (GLG). JP holds an MBA from the Kellogg School of Management at Northwestern University.

Doug joined AG Mednet in 2008 bringing to the company his vast experience in the design, development and release of fault-tolerant, high-availability systems. Architecting Judi for scale and reliability, Doug has been a pioneer in the industry in bringing advanced cloud technology to ensure both scale and cost efficiencies, incorporating advanced cloud tools for network monitoring, fast release processes and advanced storage solutions. Doug previously held managerial positions at Stratus Computer, DEC and Maptech. He holds a B.S. in Electrical Engineering from Cornell University.

Mike joined AG Mednet in 2021. A global business executive at IBM for 20 years, Svinte had leadership responsibilities for a multibillion-dollar healthcare and life sciences business. He led numerous global IBM healthcare initiatives, including launch of IBM Watson Health, led WW business development for IBM Life Sciences, and led IBM’s Information-Based Medicine startup health venture. Mike also led commercial teams as SVP for Medidata and CCO for SAP Health. He began his career at P&G in brand management and holds a B.B.A. from the University of Michigan School of Business.

Hailey, with over a decade of Strategic HR Leadership experience, brings a wealth of expertise to her role. Her innovative approach drives transformative change in HR practices, spearheading AG Mednet's success in winning the 2023 Boston Business Journal Best Places to Work award. As a culture curator and community builder, she energizes both people and leaders. Prior to joining AG Mednet, she served as the Director of People and Culture at Tremont Construction Management. Armed with a SHRM-CP certification and a Master of Business Administration from Southern Connecticut State University, Hailey leads forward-thinking HR practices, driving organizational success and fostering a dynamic workplace environment.

Jamie, joining AG Mednet in 2018, boasts over 15 years of Life Sciences experience. Their expertise spans implementing clinical technologies in diverse therapeutic domains such as Oncology, Cardiometabolic, CNS, and Immunology. Spearheading the deployment of over 100 protocols and technology setups, Jamie's track record includes facilitating drug approvals and crafting regulatory-approved eCOA forms. At AG Mednet, Jamie leads the Trial Delivery department, guiding project teams in configuring, testing, and deploying trial technology solutions on the Judi platform. They are a respected thought leader, contributing to industry publications, notably with an abstract titled "Improving diabetes patient/provider communications through optimal use of eClinical" submitted to Patient Preference and Adherence focusing on Diabetes and eCOA.

Jason joined AG Mednet in 2017, infusing the company with over a decade of software engineering experience spanning various levels. Transitioning into leadership roles concentrating on quality engineering, his impact has been profound. At AG Mednet, Jason has played a central role in fortifying the software release process, revolutionizing the SDLC methodology, and perpetually unveiling innovative features. His career journey includes tenures at esteemed organizations like Catalina Marketing, VFA, and Infosys. Armed with a B.S. in Computer Science from Syracuse University, Jason's expertise and dedication continue to propel AG Mednet's technological advancements and service excellence.

Shubha boasts more than 10 years of expertise in Regulatory and Quality within the Pharmaceuticals and Medical Devices sectors. Her proficiency in navigating intricate regulatory landscapes has seen her spearheading multiple global regulatory submissions, encompassing designations such as Orphan Drug, 510(k), IVDR implementation, and registrations across 70+ countries. Before her tenure at AG Mednet, she served as the Senior Regulatory Manager, leading the Regulatory Affairs Americas team at Epredia (formerly Thermo Fisher Scientific). Shubha's academic background includes a Master of Science in Regulatory Affairs (MSC) attained from Northeastern University, solidifying her knowledge and dedication to the field.

Josue joined AG Mednet in 2019 as a seasoned Software Support Leader, boasting over 25 years of experience in the industry. Throughout his career, he has excelled in building and mentoring award-winning support teams at prestigious tech companies across the Boston and Cambridge area, including Akamai Technologies and various high-growth tech startups. At AG Mednet, Josue has leveraged his expertise to establish a world-class support team dedicated to providing round-the-clock assistance to top pharmaceutical and clinical research organizations. His commitment to excellence is underscored by his educational background, having pursued Computer Science at the Wentworth Institute of Technology. Josue's extensive experience and leadership continue to drive success and innovation at AG Mednet.

David is a seasoned sales operations leader with over 30 years of successful experience in sales, operations, and management. He has navigated various commercial healthcare settings, including roles at Quest Diagnostics and Blue Cross Blue Shield of Massachusetts. For the past 15 years, David has been immersed in the technology sector, focusing on SaaS and enterprise solutions for both B2B and B2C markets. His entrepreneurial journey includes pivotal roles at startups like Amwell, where he spearheaded sales operations, contributing to nearly 100% year-over-year revenue and personnel growth. Known for his competitive leadership style, David excels in building results-driven sales teams that consistently surpass expectations in bookings and revenue.

In her new role as Head of Product, Jamie Russo is responsible for driving product strategy and innovation across the entire portfolio of Judi solutions, including the implementation of AI-enabled solutions across the Judi ecosystem. With over a decade of experience in the healthcare and technology sectors, Ms. Russo previously held pivotal roles at leading organizations, including PathAI, where she served as Associate Director of Platform Product Management, and Massachusetts General Hospital, where she coordinated clinical research trials in both oncology and cardiovascular research. Ms. Russo's expertise spans across product management and clinical operations, making her a key leader in advancing the intersection of technology and clinical research through the Judi platform. Ms. Russo holds a Bachelor of Arts in Neuroscience from Middlebury College.

Catherine Tyner brings 27 years of clinical research experience with a focus on Oversight Group Management for Clinical Endpoint Committees, Data Monitoring Committees, and other operations. Throughout her career, Ms. Tyner has led and developed oversight departments at Quintiles (now IQVIA), Novella Clinical, and Covance (now Fortrea), providing strategic management for over 500 clinical trials, including complex megatrials across diverse therapeutic areas. A recognized thought leader in endpoint adjudication best practices, Ms. Tyner has authored the industry's seminal guidance on adjudication operations and best practice. In her new role at AG Mednet, Ms. Tyner will work to expand and tailor the value jointly created with new and existing CROs Trial Sponsors, Core Labs, and Academic Research Organizations, working closely to optimize the future of clinical process efficiency.